Literature DB >> 7444136

1,2-Diaminocyclohexane platinum derivatives of potential clinical value.

J H Burchenal, G Irani, K Kern, L Lokys, J Turkevich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7444136     DOI： 10.1007/978-3-642-81488-4_19

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  8 in total

1.  Human ovarian-carcinoma cell lines and companion xenografts: a disease-oriented approach to new platinum anticancer drug discovery.

Authors:  L R Kelland; M Jones; G Abel; M Valenti; J Gwynne; K R Harrap
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812).

Authors:  K D Tutsch; R Z Arzoomanian; D Alberti; M B Tombes; C Feierabend; H I Robins; D R Spriggs; G Wilding
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

Review 3.  Oxaliplatin: pharmacokinetics and chronopharmacological aspects.

Authors:  F Lévi; G Metzger; C Massari; G Milano
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics and administration of established platinum drugs.

Authors:  P J O'Dwyer; J P Stevenson; S W Johnson
Journal:  Drugs       Date:  2000       Impact factor: 9.546

Review 5.  New developments and approaches in the platinum arena.

Authors:  I Judson; L R Kelland
Journal:  Drugs       Date:  2000       Impact factor: 9.546

6.  In vitro evaluation of platinum, titanium and ruthenium metal complexes in cisplatin-sensitive and -resistant rat ovarian tumors.

Authors:  S Frühauf; W J Zeller
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

7.  Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells.

Authors:  D Roberts; J Schick; S Conway; S Biade; P B Laub; J P Stevenson; T C Hamilton; P J O'Dwyer; S W Johnson
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

8.  Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes.

Authors:  C A Hills; L R Kelland; G Abel; J Siracky; A P Wilson; K R Harrap
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.